1. Approach to the true resistant hypertensive and treatment approaches
Matthew Weir 
Journal of Indian College of Cardiology 
Volume 5, Pages S33-S37 (March 2015)
DOI: /j.jicc
Copyright © Terms and Conditions

2. Fig. 1 Plasma aldosterone levels by body weight and BP status.
Journal of Indian College of Cardiology 2015 5, S33-S37DOI: ( /j.jicc )
Copyright © Terms and Conditions

3. Fig. 2 Prevalence of obstructive sleep apnea.
Source: Logan AG, et al. J Hypertens Dec;19:2271–2277
Journal of Indian College of Cardiology 2015 5, S33-S37DOI: ( /j.jicc )
Copyright © Terms and Conditions

4. Fig. 3
Nocturnal continuous positive airway pressure effect on (a) systolic BP and (b) diastolic BP over 24 h – baseline (white bars) and after 2 months (shaded bars). PAC – Plasma aldosterone concentration, PA – Primary aldosteronism.
Source: Logan AG et al. Eur Respir J Feb;21:241–247
Journal of Indian College of Cardiology 2015 5, S33-S37DOI: ( /j.jicc )
Copyright © Terms and Conditions

5. Fig. 4
Aldosterone levels and risk of OSA in resistant hypertensive patients.
Source: Calhoun DA, et al. Chest Jan;125:112–117
Journal of Indian College of Cardiology 2015 5, S33-S37DOI: ( /j.jicc )
Copyright © Terms and Conditions

6. Fig. 5
(a) AHI and HI correlation with plasma aldosterone levels in resistant hypertension patients (AHI: rho = 0.44, p=0.0002; HI: rho = 0.38, p=0.001). (b)AHI and HI correlation with plasma aldosterone levels in normal patients (AHI: rho = 0.12, p=0.52; HI: rho = 0.002, p=0.99).
Source: Pratt-Ubunama MN,et al. Chest Feb;131:453–459
Journal of Indian College of Cardiology 2015 5, S33-S37DOI: ( /j.jicc )
Copyright © Terms and Conditions

7. Fig. 6
Effect of spironolactone on AHI in patients with resistant hypertension and moderate-severe OSA.
Journal of Indian College of Cardiology 2015 5, S33-S37DOI: ( /j.jicc )
Copyright © Terms and Conditions